Value of baseline ^(18)F-FDG PET/CT metabolism parameters in patients with stage Ⅲ-Ⅳ lung adenocarcinoma before EGFR-TKI monotherapy  

作　　者：CUI Yan 崔燕(Dept Nucl Med,Beijing Hosp,Natl Gerontol CenterInstit Geriatr Med,CAMS,Beijing 100730,China)

机构地区：[1]Dept Nucl Med,Beijing Hosp,Natl Gerontol CenterInstit Geriatr Med,CAMS,Beijing 100730,China

出　　处：《China Medical Abstracts(Internal Medicine)》2024年第3期130-131,共2页中国医学文摘（内科学分册英文版）

摘　　要：Objective To investigate the efficacy and prognostic value of baseline ^(18)F-FDG PET/CT metabolism parameters in patients with stageⅢ-Ⅳlung adenocarcinoma before epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) monotherapy.

关 键 词：PET/CT TKI BEFORE 

分 类 号：R734.2[医药卫生—肿瘤]